Stocks To Buy Forum

Stocks to Buy based on the Best Stock Market Research

John James
  • Male
  • Frankfurt
  • Germany
Share

John James's Discussions

KTOV (MC $16 M) (Cash $17 M) US-NDA Submission for Big Drug this Quarter
1 Reply

another super hot and dirt cheap FDA playKTOV (MC $16 M) (Cash $17 M) US-NDA Submission for their osteoarthritis pain and hypertension drug exptected this Quarter. This ultra low float stock will be…Continue

Started this discussion. Last reply by John James Jul 19.

ACRX (MC $97 M) Cash $72 M / FDA Decision on Oct 12 / P3 results this month
1 Reply

FDA Decision in October for potential Blockbuster and Phase 3 readout this month for another Drug = SUPER HOT AND DIRRT CHEAP FDA GEM ACRX (MC $97 M) Cash $72 M / FDA Decision on Oct 12 / P3…Continue

Started this discussion. Last reply by John James Jul 17.

AXSM (MC $83 M)(Cash $50 M) 4x BIG Phase 3 in various indication ongoing =TOP PICK
8 Replies

Very attractive and massive undervalued Biotech Stock with many Major News on the way . Axsome has 4 Phase 3 clinical trials ongoing in various indication targeting very large Markets .This Stock is…Continue

Started this discussion. Last reply by Stocks To Buy Jun 20.

RDHL (MC $150 M) $60+ M Cash / 3 MEGA Drugs with P3 results in 1H 2017
1 Reply

RDHL is a brutally undervalued and almost unknown gem with many News coming within 6-7 months including Phase 3 Results from 2 Potential Blockbusters and NDA resubmission in early 2017 . Market Cap…Continue

Started this discussion. Last reply by John James Dec 27, 2016.

 

John James's Page

Latest Activity

John James replied to John James's discussion KTOV (MC $16 M) (Cash $17 M) US-NDA Submission for Big Drug this Quarter
"An older article but nice one which shows the massive potential here https://seekingalpha.com/article/3939596-kitov-pharmaceuticals-bullish-valuation-based-comparablesConclusionIn my original article, I ballparked KTOV's valuation at $22.50 per…"
Jul 19
John James posted a discussion

KTOV (MC $16 M) (Cash $17 M) US-NDA Submission for Big Drug this Quarter

another super hot and dirt cheap FDA playKTOV (MC $16 M) (Cash $17 M) US-NDA Submission for their osteoarthritis pain and hypertension drug exptected this Quarter. This ultra low float stock will be one of the hottest and most underpriced FDA play i ever have seen in last 20 years in stock trading. KTOV has really more than 10 bagger potential the stock is trading at cash level and the valuation is ONLY $16 Million i cant believe it but please do your own dd and realize the brutal potential…See More
Jul 19
John James replied to John James's discussion ACRX (MC $97 M) Cash $72 M / FDA Decision on Oct 12 / P3 results this month
"Nice jump in Pre-Mkt and we are just days away before phase 3 results will be released and 3 months before FDA decision so there is good chance for a run close or maybe even over $10 .GL Upcoming Major Milestones Zalviso Phase 3 Results in July…"
Jul 17
John James posted a discussion

ACRX (MC $97 M) Cash $72 M / FDA Decision on Oct 12 / P3 results this month

FDA Decision in October for potential Blockbuster and Phase 3 readout this month for another Drug = SUPER HOT AND DIRRT CHEAP FDA GEM ACRX (MC $97 M) Cash $72 M / FDA Decision on Oct 12 / P3 results this month...Im in as well guys love it . Very attractive and dirt cheap FDA Play ..... ACRX has 2 Products including potential Blockbuster under review by FDA and MAA (Europe) . Upcoming Milestones : Zalviso (Pain) final Phase 3 results this month // DSUVIA (Pain) with FDA Decision on October…See More
Jul 14
John James replied to John James's discussion IGXT (MC $32 M) 2 FDA approvals coming + 2 New NDA Submissions in 4Q = 10+ BAGGER EASILY
"Heavily undervalued stock with so many big milestones on the way , could be hottest and cheapest FDA play for the next 9-12 months . This Stock could run to $3+ before FDA decision .GL Market cap $55 million Upcoming Milestones: NDA submission…"
Jun 23
Stocks To Buy replied to John James's discussion AXSM (MC $83 M)(Cash $50 M) 4x BIG Phase 3 in various indication ongoing =TOP PICK
"Jumping today, nice stock pick!"
Jun 20
John James replied to John James's discussion AXSM (MC $83 M)(Cash $50 M) 4x BIG Phase 3 in various indication ongoing =TOP PICK
"Nice price jump looks like its on the way to break the size back the MA(200) at $5.54 .With positive phase 3 results in the coming weeks this low float stock will jump close or even above $10 ."
Jun 20
John James replied to John James's discussion AXSM (MC $83 M)(Cash $50 M) 4x BIG Phase 3 in various indication ongoing =TOP PICK
"Nice move today ,, Start Phase 2/3 of Alzheimer agitation trial within days...... Nice move today ,, Start Phase 2/3 of Alzheimer agitation trial within days......Nice move today ,, Start Phase 2/3 of Alzheimer agitation trial within days ..."
Jun 6
John James replied to John James's discussion AXSM (MC $83 M)(Cash $50 M) 4x BIG Phase 3 in various indication ongoing =TOP PICK
"Another Guy likes AXSM ...more and more people discover this stock and realize the mega potential here https://seekingalpha.com/instablog/498952-bret-jensen/4989021-axsome-therapeutics-4-biotech-stock-worthy-investment"
May 16
John James replied to John James's discussion AXSM (MC $83 M)(Cash $50 M) 4x BIG Phase 3 in various indication ongoing =TOP PICK
"Fantastic News out today...Axsome Therapeutics Receives FDA Fast Track Designation for AXS-05 for Alzheimer’s Disease…"
May 8
John James replied to John James's discussion AXSM (MC $83 M)(Cash $50 M) 4x BIG Phase 3 in various indication ongoing =TOP PICK
"Need to break the MA(50) at $4.24 then $5+ coming"
Apr 26
John James replied to John James's discussion AXSM (MC $83 M)(Cash $50 M) 4x BIG Phase 3 in various indication ongoing =TOP PICK
"here we go guys we are over $4 ,, this stock is what i call a once in a lifetime opp this stock should be at $20 right now not at laughable $4 . 5 Phase 3 Programs two of them targeting very large Markets with NO approved Drugs . Marketcap: $90…"
Apr 11
John James replied to John James's discussion AQSZF (MC $10 M) 2 Marketed Drugs & 3 Drugs nearing Approval = FANTASTIC OPP
"GREAT News out , this product alone could bring as much as $200 million in annual revenue and this unknown goldmine is value at laughable $14 million .This one has reallly 20 bagger potential if everything goes well .GL Aequus Pharmaceuticals :…"
Apr 3
John James replied to John James's discussion AXSM (MC $83 M)(Cash $50 M) 4x BIG Phase 3 in various indication ongoing =TOP PICK
"maybe the cheapest Nasdaq Biotech you can get with 5x Phase 3 in various indications and a laughable Market cap of $85 Million and $50 Million in cash .The fair value should be at $8-10 right now for this unknown Biotech .Latest stock market analyst…"
Mar 27
John James posted a discussion

AXSM (MC $83 M)(Cash $50 M) 4x BIG Phase 3 in various indication ongoing =TOP PICK

Very attractive and massive undervalued Biotech Stock with many Major News on the way . Axsome has 4 Phase 3 clinical trials ongoing in various indication targeting very large Markets .This Stock is brutally undervalued with Market cap of $83 million and $50 million in cash .Founder and Ceo is the larget shareholder holding over 7 million shares (30%) over 50% of O/S is owned by Insider and Institutions which is a good sign .This undiscovered goldmine could be the next 10 bagger gem if just…See More
Mar 22
John James replied to John James's discussion AQSZF (MC $10 M) 2 Marketed Drugs & 3 Drugs nearing Approval = FANTASTIC OPP
Mar 2

Comment Wall

You need to be a member of Stocks To Buy Forum to add comments!

Join Stocks To Buy Forum

  • No comments yet!
 
 
 

Stocks to Buy 2017

Stocks to Buy 2017

Small Cap Bull 3x (TNA)
Shake Shack (SHAK)
Stocks to Watch - 2018
Penny Stocks - 2018



Twitter - Free Stock Alerts

© 2017   Created by Stocks To Buy.   Powered by

Badges  |  Report an Issue  |  Terms of Service